China’s COVID-19 vaccine candidate shows promise in human trials, CNBG says
BEIJING/SINGAPORE (Reuters) – China National Biotec Group (CNBG) said on Tuesday its experimental coronavirus vaccine has triggered antibodies in clinical trials and the company plans late-stage human trials in foreign countries. No vaccines have been solidly proven to be able to effectively protect people from the virus that has killed more than 400,000 people, while… Read More »